Effect of the addition of pre-biotics to infant formula on markers of immune development and atopy at 5 years of age

Completed

• Conditions: allergy; infections; 10001708; 10019815

• Registration Number: NL-OMON35946
• Lead Sponsor: Danone Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 156

Inclusion Criteria

Infants who participated in the MIPS-1 study and agreed to participate in the follow-up MIPS-II study

Exclusion Criteria

children from whom the parents do not give consent for blood sampling

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>levels of IgE and subclasse, TARC, light chain IgG and titers against HiB and<br /><br>tetanus</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>